본문 바로가기
주메뉴 바로가기
HLBELL
ABOUT US
Greeting
What We Do
Corporate Philosophy
Main History
Organization
Location
Technology
Hutrigel® (Human Extracellular Matrix)
BleeFix® (Hemostat)
LifeLiver® (Bioartificial Liver Support System)
Intellectual Property Rights
Pipeline
Development Stage
Product
Primary Human Hepatocytes
Primary Animal Hepatocytes
PR
Notice
News
Sitemap
Contact
ENG
KOR
ENG
ABOUT US
Greeting
What We Do
Corporate Philosophy
Main History
Organization
Location
Technology
Hutrigel® (Human Extracellular Matrix)
BleeFix® (Hemostat)
LifeLiver® (Bioartificial Liver Support System)
Intellectual Property Rights
Pipeline
Development Stage
Product
Primary Human Hepatocytes
Primary Animal Hepatocytes
PR
Notice
News
SITEMAP
ABOUT US
Greeting
What We Do
Corporate Philosophy
Main History
Organization
Location
Technology
Hutrigel® (Human Extracellular Matrix)
BleeFix® (Hemostat)
LifeLiver® (Bioartificial Liver Support System)
Intellectual Property Rights
Pipeline
Development Stage
Product
Primary Human Hepatocytes
Primary Animal Hepatocytes
PR
Notice
News
PR
Biotech Company Specialized in Regenerative Medicine
News
Notice
News
News
HLB셀, 지혈제 '블리픽스' 임상 성공…"올해 말 품목 허가 목표"
Date 2025.05.27
Hit 4394
기사원문 : https://
www.news1.kr/bio/pharmaceutical-bio/5795268
PREV
HLB제약·HLB셀, '바이오USA' 참가…글로벌 기술 협력 본격화
NEXT
HLB셀, 피부조직 재생시켜 주름 없애는 '차세대 필러' 개발 추진
LIST